BlackRock Discloses Significant Stake in INDIVIOR PLC
Ticker: INDV · Form: SC 13G · Filed: Feb 2, 2024 · CIK: 1625297
| Field | Detail |
|---|---|
| Company | Indivior PLC (INDV) |
| Form Type | SC 13G |
| Filed Date | Feb 2, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, SC-13G, BlackRock, pharmaceuticals
TL;DR
**BlackRock owns a piece of Indivior, signaling institutional confidence.**
AI Summary
BlackRock Inc. has filed an SC 13G indicating its ownership stake in INDIVIOR PLC as of December 31, 2023. This filing, made under Rule 13d-1(b), shows that BlackRock, a major institutional investor, holds a significant position in the pharmaceutical company. This matters to investors because large institutional holdings can signal confidence in a company's future prospects and can influence stock stability.
Why It Matters
This filing reveals that a major institutional investor, BlackRock, has a notable stake in INDIVIOR PLC, which can be seen as a vote of confidence in the company.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present a direct risk to investors.
Analyst Insight
Smart investors should note BlackRock's institutional ownership as a potential indicator of long-term value, but should conduct further due diligence on INDIVIOR PLC's fundamentals and market position.
Key Players & Entities
- BlackRock Inc. (company) — reporting person and institutional investor
- INDIVIOR PLC (company) — subject company, pharmaceutical preparations
- December 31, 2023 (date) — date of event requiring the filing
- Rule 13d-1(b) (person) — SEC rule under which the filing was made
Forward-Looking Statements
- BlackRock will maintain its stake in INDIVIOR PLC. (BlackRock Inc.) — medium confidence, target: Q2 2024
FAQ
What type of filing is this document?
This document is an SC 13G filing, specifically under Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the reporting person in this SC 13G filing?
The reporting person is BlackRock, Inc., with a business address at 50 Hudson Yards, New York, NY 10001.
What is the name of the issuer whose securities are being reported?
The name of the issuer is INDIVIOR PLC, a company in the pharmaceutical preparations industry.
What is the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
What is the SEDOL number for the class of securities reported?
The SEDOL number for the Common Stock of INDIVIOR PLC is BP0BQQ5.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on February 2, 2024 by Rule 13d-1(b) regarding INDIVIOR PLC (INDV).